---
title: "First patients treated with Duo tricuspid coaptation system in TANDEM II study"
date: "2024-10-25T09:25:50.000Z"
publishedDate: "25 octobre 2024"
summary: "CroíValve has announced the first patient treated with the Duo system as part of the TANDEM II early feasibility study in the USA. The Duo system is a transcatheter valve that works in tandem with the native tricuspid valve to restore valve function while preserving the native valve apparatus."
importance: ""
sourceUrl: "https://cardiovascularnews.com/tandem-ii-first-cases/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2024-10-25-first-patients-treated-with-duo-tricuspid-coaptation-system-in-tandem-ii-study"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2024/08/DUO_System_Inside_Heart_Imge_edited.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/tandem-ii-first-cases/"
---

![First patients treated with Duo tricuspid coaptation system in TANDEM II study](https://cardiovascularnews.com/wp-content/uploads/sites/14/2024/08/DUO_System_Inside_Heart_Imge_edited.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/tandem-ii-first-cases/*

## L’essentiel

CroíValve has announced the first patient treated with the Duo system as part of the TANDEM II early feasibility study in the USA. The Duo system is a transcatheter valve that works in tandem with the native tricuspid valve to restore valve function while preserving the native valve apparatus.

## Lien source

https://cardiovascularnews.com/tandem-ii-first-cases/
